Bioventus (NASDAQ:BVS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Bioventus missed estimated earnings by 20.0%, reporting an EPS of $0.04 versus an estimate of $0.05.
Revenue was up $35.51 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 0.43% drop in the share price the next day.
Here's a look at Bioventus's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.18 | 0.14 | 0.15 | 0.09 |
| EPS Actual | 0.26 | 0.25 | 0.16 | 0.15 |
| Revenue Estimate | 130.29M | 102.23M | 97.64M | 76.54M |
| Revenue Actual | 130.41M | 108.89M | 109.82M | 81.78M |
To track all earnings releases for Bioventus visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
